We previously used the triazacyclononane-triphosphinate (TRAP) chelator scaffold13 to elaborate highly symmetrical trimers14 of various tumor targeting motifs, such as prostate-specific membrane antigen (PSMA) inhibitors15 and ligands for the integrins αvβ3,16 α5β1,17 αvβ8,18 and αvβ6.19 After efficient labeling with the positron emitter gallium-68 (68Ga),20 these trimers were applied for positron emission tomography (PET) imaging of human tumor xenografts in rodent models. Here, FOLH1 is linked to neoplasm.